Safety Advisory: A dose-dependent increase in the risk of atrial fibrillation has been consistently observed in major trials, especially at the 4 g/day dose, prompting regulatory safety advisories ( Guideline Recommendations: Based on this evidence, major guidelines now endorse the selective use of icosapent ethyl
Analysis of the data indicates that short-term treatment with RM-493 increased resting energy expenditure significantly (by 6.4% vs placebo), thus suggesting RM-493 may be clinically effective for treating obesity
PT-141 is a peptide hormone that increases sexual arousal in both men and women
Nevertheless, despite the potential of BDCMs in energy conversion applications, significant challenges remain
Answering this question is the key to your long-term health
Key Policy: BALANCE and Bridge To understand where Medicare GLP-1 coverage is headed, you need to understand two programs: Bridge and BALANCE